Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Individuals With Acute HIV Infection

NCT04505501 is registered in ClinicalTrials.gov with Thai Red Cross AIDS Research Centre as lead sponsor.

NCT NCT04505501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04505501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Individuals With Acute HIV Infection
Lead sponsor
Thai Red Cross AIDS Research Centre
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 1, 2021
Completion date
June 30, 2025
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids